JP Morgan Chase’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-220,000
Closed -$4.67M 5247
2019
Q4
$4.67M Sell
220,000
-129,700
-37% -$2.88M ﹤0.01% 2732
2019
Q3
$8.03M Sell
349,700
-270,900
-44% -$6.18M ﹤0.01% 2305
2019
Q2
$14.8M Buy
620,600
+347,000
+127% +$7.14M ﹤0.01% 1795
2019
Q1
$3.55M Buy
273,600
+75,800
+38% +$1.33M ﹤0.01% 2879
2018
Q4
$2.98M Buy
+197,800
New +$5.12M ﹤0.01% 2974
2018
Q2
Sell
-49,300
Closed -$2.95M 5523
2018
Q1
$2.95M Sell
49,300
-188,900
-79% -$12.6M ﹤0.01% 3002
2017
Q4
$18.7M Buy
238,200
+158,200
+198% +$12.8M ﹤0.01% 1619
2017
Q3
$6.73M Buy
80,000
+38,200
+91% +$2.71M ﹤0.01% 2317
2017
Q2
$2.73M Buy
41,800
+10,000
+31% +$680K ﹤0.01% 2864
2017
Q1
$2.31M Buy
+31,800
New +$2.09M ﹤0.01% 2953

Other funds holding ADNT

JP Morgan Chase's ADNT Position: Q2 2026 in Review

JP Morgan Chase increased its Adient (ADNT) stake by 73% in Q2 2026, buying an estimated $9.75M and bringing the position to 1,082,233 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

JP Morgan Chase first reported a position in ADNT in Q4 2016 and has held it in 37 quarters since. The position peaked at $46M in Q1 2021. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • JP Morgan Chase held 1,082,233 shares of Adient worth $19.7M as of Q2 2026.
  • JP Morgan Chase bought 456,081 Adient shares in Q2 2026, an estimated $9.75M.
  • Adient made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2233 holding.
  • JP Morgan Chase first reported a position in Adient in Q4 2016 and has held it in 37 quarters since.
  • JP Morgan Chase's Adient position peaked at $46M in Q1 2021.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.